Notably, tissue expression of PD-L1 was variable; in 45% of subjects the PD-L1 tumor proportional score (TPS) was < 1%, in 27.5% was in the 1–49% range and in 27.5% was ≥ 50%. Here, CD274 is linked to neoplasm.